Product Information
OXCARBAZEPINE ER 300 MG TABLET is a generic product labeled by Apotex Corp., priced at $4.5729 per EA under NDC 60505412907. Its NADAC has been published 84 times since Nov 20, 2024.
The High Outlier badge above means this manufacturer's average price in the OXCARBAZEPINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Apotex Corp.NDC
60505412907
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA213369On Market Since
9/3/2024
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE ER 300 MG TABLET has been published 84 times since Nov 20, 2024, and over the history we have for it it has declined 52.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5729 per EA |
|---|---|
| All-time high | $9.6183 (Dec 11, 2024) |
| All-time low | $4.5729 (Jun 17, 2026) |
| 52-week high | $9.0124 |
| 52-week low | $4.5729 |
| Median price | $8.3822 |
| Average price | $8.0711 |
| Largest weekly change | -13.7% (Apr 22, 2026) |
| Weeks tracked | 84 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE ER 300 MG TABLET, manufactured by Apotex Corp., is $4.5729 per EA (NDC 60505412907), effective Jun 24, 2026.
How has the price of OXCARBAZEPINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE ER 300 MG TABLET has declined 52.5%. It has been tracked across 84 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE ER 300 MG TABLET?
Since Nov 20, 2024, the NADAC for OXCARBAZEPINE ER 300 MG TABLET has ranged from a low of $4.5729 (Jun 17, 2026) to a high of $9.6183 (Dec 11, 2024), with a median of $8.3822 per EA.
Are there cheaper alternatives to OXCARBAZEPINE ER 300 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OXCARBAZEPINE 300 MG TABLET, is $0.1664 per EA — about 96% below OXCARBAZEPINE ER 300 MG TABLET.
Who manufactures OXCARBAZEPINE ER 300 MG TABLET?
OXCARBAZEPINE ER 300 MG TABLET (NDC 60505412907) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification